Medicare Enrolled
Dr. Elizabeth Kent, M.D.
Hematology · Fleming Island, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kent from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kent?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kent
Dr. Elizabeth Kent is a hematology specialist in Fleming Island, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Kent performed 32,558 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Kent received a total of $7,685 from 73 pharmaceutical and/or device companies across 442 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kent is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ 32,558 Medicare services
$7,685 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 116639 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗32,558
Medicare services
Bottom 31% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
12,750 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 8,880 | $19 | $51 |
| Iron infusion (Monoferric) | 3,500 | $17 | $57 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,000 | $6 | $23 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
974 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
846 | $8 | $29 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
528 | $0 | $3 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
435 | $94 | $339 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
403 | $62 | $239 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
378 | $10 | $69 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
188 | $21 | $84 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
124 | $45 | $189 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
113 | $93 | $378 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
111 | $1 | $6 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
103 | $25 | $89 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
43 | $21 | $79 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
42 | $1 | $3 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
30 | $75 | $298 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $140 | $474 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
29 | $2 | $7 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $131 | $453 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
25 | $11 | $61 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
51.3% high complexity
40.3% medium
8.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,685
Total received (2018-2024)
Avg $1,098/year across 7 years
Top 48% in FL for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
442
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,563
2023
$1,063
2022
$1,019
2021
$480
2020
$766
2019
$1,405
2018
$1,389
Payments by company (2024)
PFIZER INC.
$213
Merck Sharp & Dohme LLC
$191
Novartis Pharmaceuticals Corporation
$162
Alexion Pharmaceuticals, Inc.
$100
Gilead Sciences, Inc.
$88
AstraZeneca Pharmaceuticals LP
$62
GENZYME CORPORATION
$60
Takeda Pharmaceuticals U.S.A., Inc.
$59
E.R. Squibb & Sons, L.L.C.
$57
Lilly USA, LLC
$46
Mirati Therapeutics, Inc.
$46
GlaxoSmithKline, LLC.
$44
Celgene Corporation
$42
Astellas Pharma US Inc
$41
Genentech USA, Inc.
$40
Regeneron Healthcare Solutions, Inc.
$33
Kite Pharma, Inc.
$27
Janssen Biotech, Inc.
$24
Fennec Pharmaceuticals, Inc.
$24
TerSera Therapeutics LLC
$23
SOBI, INC
$23
Daiichi Sankyo Inc.
$21
Pharmacosmos Therapeutics Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
Incyte Corporation
$18
ARRAY BIOPHARMA INC
$17
TAIHO ONCOLOGY, INC.
$17
BeiGene USA, Inc.
$15
MorphoSys, US Inc.
$15
ABBVIE INC.
$14
Top 3 companies account for 36.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$842
E.R. Squibb & Sons, L.L.C.
$493
Merck Sharp & Dohme Corporation
$428
Merck Sharp & Dohme LLC
$419
PFIZER INC.
$381
Janssen Biotech, Inc.
$359
Genentech USA, Inc.
$298
Amgen Inc.
$265
Lilly USA, LLC
$265
Gilead Sciences, Inc.
$256
Astellas Pharma US Inc
$237
AstraZeneca Pharmaceuticals LP
$199
Alexion Pharmaceuticals, Inc.
$198
GENZYME CORPORATION
$187
Incyte Corporation
$182
GlaxoSmithKline, LLC.
$179
Seagen Inc.
$174
Takeda Pharmaceuticals U.S.A., Inc.
$159
Exelixis Inc.
$143
EMD Serono, Inc.
$125
Foundation Medicine, Inc.
$105
Celgene Corporation
$104
Seattle Genetics, Inc.
$96
Daiichi Sankyo Inc.
$94
Taiho Oncology, Inc.
$86
Ipsen Biopharmaceuticals, Inc
$76
Rigel Pharmaceuticals, Inc.
$72
Global Blood Therapeutics, Inc.
$67
ARRAY BIOPHARMA INC
$66
Regeneron Healthcare Solutions, Inc.
$64
Mirati Therapeutics, Inc.
$63
Kite Pharma, Inc.
$55
Lexicon Pharmaceuticals, Inc.
$54
ABBVIE INC.
$50
BeiGene USA, Inc.
$47
Bayer HealthCare Pharmaceuticals Inc.
$47
TerSera Therapeutics LLC
$41
TESARO, Inc.
$40
MorphoSys, US Inc.
$39
EISAI INC.
$38
TAIHO ONCOLOGY, INC.
$36
Eisai Inc.
$35
MEDIVATION FIELD SOLUTIONS LLC
$28
Aurobindo Pharma USA, Inc.
$26
Octapharma USA, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$24
Fennec Pharmaceuticals, Inc.
$24
Pharmacyclics LLC, An AbbVie Company
$23
SOBI, INC
$23
Lundbeck LLC
$23
Emmaus Medical, Inc.
$22
Boehringer Ingelheim Pharmaceuticals, Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
Aveo Pharmaceuticals, Inc.
$19
G1 Therapeutics, Inc.
$19
TG Therapeutics, Inc.
$17
SERVIER PHARMACEUTICALS LLC
$17
Janssen Scientific Affairs, LLC
$17
INSYS Therapeutics Inc
$16
AbbVie Inc.
$16
AVEO Pharmaceuticals, Inc.
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
Puma Biotechnology, Inc.
$13
Karyopharm Therapeutics Inc.
$13
Adaptive Biotechnologies Corporation
$13
Pharmacyclics LLC, an AbbVie Company
$12
AbbVie, Inc.
$12
Dova Pharmaceuticals
$11
Helsinn Therapeutics (U.S.), Inc.
$11
Janssen Pharmaceuticals, Inc
$10
Heron Therapeutics, Inc.
$8
Sirtex Medical Inc
$7
Veracyte, Inc.
$2
Top 3 companies account for 22.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Cinvanti · DARZALEX · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ERLEADA · Endari · Enhertu · Erivedge · Erleada · FEMARA · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INQOVI · INREBIC · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · Marqibo · NERLYNX · NINLARO · Nexavar · Nplate · Nubeqa · OCREVUS · OJJAARA · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · PADCEV · PANZYGA · PIQRAY · PLUVICTO · PROMACTA · Padcev · Pedmark · Perjeta · Polivy · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNAGIS · SYNDROS · TAGRISSO · TASIGNA · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · VENCLEXTA · VERZENIO · VOTRIENT · VYEPTI · Venclexta · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · Zevalin · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
13
County median income
$86,094
Nearest hospital to ZIP centroid (approximate)
HCA FLORIDA ORANGE PARK HOSPITAL
5.3 mi
5.3 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kent is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kent experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kent performed 12,750 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Kent receive payments from pharmaceutical companies?
Yes. Dr. Kent received a total of $7,685 from 73 companies across 442 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kent's costs compare to other hematologists in Fleming Island?
Dr. Kent's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kent) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Fleming Island
Browse hematologists in Fleming Island ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology